首页 | 本学科首页   官方微博 | 高级检索  
     


Calcium signaling is implicated in the diffuse axonal injury of brain stem
Authors:Jiao Mu  Yucheng Song  Ji Zhang  Wei Lin  Hongmei Dong
Affiliation:1Department of Forensic Medicine, Huazhong University of Science and Technology, Tongji Medical College, No. 13 Hangkong Lu, Hankou, Wuhan 430030, Hubei, PR China;2Department of Pathology, Hebei North University, No. 11 Zuanshinan Lu, Zhangjiakou 075000, Hebei, PR China;3Criminal Investigation Brigade of Taicang, No. 128 Loujiangbei Lu, Taicang, Suzhou 215400, Jiangsu, PR China
Abstract:Evaluating diffuse axonal injury (DAI) remains challenging in clinical sciences since the physiopathologic mechanism of DAI is still unclear. The calcium overload in the axoplasm is considered to be crucial for secondary axonal injury. The present study use calcium channel blocker, nimodipine, to explore the influence of Ca2+ in the pathogenesis of rat DAI. In the DAI group, the expressions of β-APP and NF-L in axons were increased from 12 to 72 h. The ultrastructural observation indicated the axon and vessel injury appeared at 12 h post-injury and severely aggravated from 24 to 72 h. The expression of vWF and brain water content was increased at 12 h after injury and further increased at 24 h. Nimodipine decreased the expression of β-APP, NF-L and vWF, and also attenuated the ultrastructural damage of vascular wall and axons. Furthermore, Ca-dependent enzyme, the calcineurin activity were increased in DAI and nimodipine suppressed the activity of calcineurins (CaN). However, the amount of CaN expression was not changed. Our results showed that disturbances of axonal calcium homeostasis play an important role in the secondary damage of the axon, neuron and capillary vessel which may be related with activating CaN during the acute phase of DAI. Nimodipine can alleviate the secondary damage by suppressing the calcineurin activity.
Keywords:Diffuse axonal injury   calcium signal   nimodipine   animal study
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号